Medicine Overview of Zomibet Injection
Reduced blood platelets, Fatigue, Peripheral neuropathy (tingling and numbness of feet and hand), Psychiatric disturbances, Nausea, Vomiting, Loss of appetite, Fever, Anemia, Diarrhoea, Decreased appetite, Decreased white blood cell count (neutrophils), Constipation.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Zomibet 2mg Injection is an anti-cancer medication. It works by blocking or slowing the breakdown of proteins in cells. As a result, there is an increase in a number of proteins in the cancer cells leading to their death.
In Depth Information on Zomibet Injection
- Before taking bortezomib, consult your doctor if you have any of the following disease conditions: disease of liver, kidney, heart or infections like fever with rash or genital sores, diabetes, low number of red or white blood cells or bleeding problems.
- Drink plenty of fluids every day during your treatment with bortezomib.
- Tell your doctor if you are or planning to become pregnant or are breastfeeding.
- Consult your doctor if you have signs of serious brain infection such as memory loss, trouble in thinking, difficulty with walking or loss of vision.
- Do not drive or operate machinery after taking bortezomib as it may cause tiredness, dizziness, fainting or blurred vision.
Zomibet Injection related warnings
Interaction with alcohol is unknown. Please consult your doctor.
WEIGH RISKS VS BENEFITS
Zomibet 2mg Injection is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Zomibet 2mg Injection is unsafe to use during lactation.
Data suggests that the drug may cause toxicity to the baby, or the mother is suffering from a condition in which breastfeeding is not advisable.
Do not drive unless you are feeling well.
Zomibet 2mg Injection might cause tiredness, dizziness, fainting, or blurred vision which may affect your ability to drive.
Zomibet 2mg Injection should be used with caution in patients with severe kidney disease. Dose adjustment of Zomibet 2mg Injection may be needed. Please consult your doctor.
Limited information is available on the use of Zomibet 2mg Injection in these patients.
Zomibet 2mg Injection should be used with caution in patients with liver disease. Dose adjustment of Zomibet 2mg Injection may be needed. Please consult your doctor.
If you miss a dose of Zomibet 2mg Injection, please consult your doctor.
Frequently asked questions about Zomibet Injection
Zomibet is not a hormone. It is a chemotherapy/ cytotoxic drug used in the treatment of cancers including multiple myeloma and mantle cell lymphoma
Zomibet belongs to the class of drugs called a proteasome inhibitor. It acts by blocking the action of proteasome, and affects the growth of cancerous (actively growing) cells
Yes, Zomibet is approved by FDA
Yes, Zomibet is dialyzable
Zomibet can cause toxic effects if not given in appropriate dose although not everybody gets them
Zomibet may cause side effects such as constipation.
One of the following vendor pharmacies will deliver Zomibet 2mg Injection: PLT, OLT, AGT, MSD, SWP, MPC, PNT, BBS, TNH, GBL, DPP, SWA, NNH, HPC, RSS, DDR, RKS, SCH, STA, DLP, ADT, SRG, MAX, MOM, CLT, ZVP, BMJ, SHD, JMJ, BIO, OIP, IPL, ENP, INC, SVH, OHM, RUS, SYN, WSI, TRP, JIV, AYU, RWP, GTC, GNC, PVP, AAY, EMB, SAT, HGI, ATL, SAF, RPP, NDP, SDM, BTM, PTI, HBV, TOM, NSL, VRS, HMP, WHL, RHW, ANT, HAT, LHA, SSA, SBA, RJH, MDO, ABP, BSN, PEN, MAK, 9T9, JVO, KHH, FGH, RHL, THP, DYG, ARD, GPT, OWP, BAL, ZEL, GPP, SBL, HIP, PPR, NWP, BHP, DPL, PRN, LCC, AVN, IAD, NVY, GTK, MLC, DHR, UMP, PWN, AMR, NVL, RSA, USF, ATP, SJP, SHP, NXG, NTB, DFP, MAM, HEX, MMS, SGC, JVN, DGN, AAR, BDN, EQN